Anticholinergics

Abood, Leo G.

doi:10.1007/978-3-642-67770-0_15

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1984

1998

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, steric e †ects are important in optimizing interactions between glycolate and receptor. 6 Owing to its strong psychosomimetic e †ect, compound 1 has potential as a chemical warfare agent7 and its production, use and stockpiling are prohibited by the Chemical Weapons Convention.8 3-Quinuclidinol (2) (1-azabicyclo[2.2.2]octan-3-ol) is a precursor and degradation product of 1.…”

Section: Introductionmentioning

confidence: 99%

NMR spectral analysis and molecular dynamics study of 3-quinuclidinol and 3-quinuclidinyl benzilate

Heikkinen¹,

Mesilaakso²,

Rahkamaa³

1998

Magn. Reson. Chem.

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

NMR spectral analysis and molecular dynamics study of 3-quinuclidinol and 3-quinuclidinyl benzilate

Heikkinen¹,

Mesilaakso²,

Rahkamaa³

1998

Magn. Reson. Chem.

View full text Add to dashboard Cite

Biphasic effects of 3-quinuclidinyl benzilate on spontaneous motor activity in mice

Liu

Beaton³

1984

Psychopharmacology

View full text Add to dashboard Cite

Dose-response relationships for onset, duration, and magnitude of 3-quinuclidinyl benzilate (QNB) on spontaneous motor activity (SMA) were studied in mice. QNB was administered SC immediately before 2-h test sessions in dose levels differing by a factor of 0.5 log (range 0.1-10.0 mg/kg). For the total activity session of 2 h, QNB had a biphasic effect on SMA; at a low dose (0.1 mg/kg) it decreased, and at moderate to higher doses (0.3-10.0 mg/kg) it increased SMA in a dose-related fashion. The onset and duration of the significant decreasing or increasing effects were also dose dependent; at the low dose (0.1 mg/kg) it depressed SMA from 5 to 35 min postinjection, at moderate doses (0.3 and 1.0 mg/kg) it enhanced SMA from 5 to 45 min and 5 to 70 min, respectively, postinjection. At the higher doses (3.0 and 10.0 mg/kg) it increased SMA within 5 min and lasted for 100 and 120 min, respectively. The increase in SMA for the dose range from moderate to high doses of QNB (0.3-10.0 mg/kg) was linear with dose. In general, QNB appears to produce a biphasic effect on SMA responding in mice.

show abstract

Anticholinergics

Cited by 2 publications

References 45 publications

NMR spectral analysis and molecular dynamics study of 3-quinuclidinol and 3-quinuclidinyl benzilate

NMR spectral analysis and molecular dynamics study of 3-quinuclidinol and 3-quinuclidinyl benzilate

Biphasic effects of 3-quinuclidinyl benzilate on spontaneous motor activity in mice

Contact Info

Product

Resources

About